Skip to main content
ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
1.450
-0.490 (-25.26%)
Nov 7, 2024, 3:31 PM EST - Market open

ProPhase Labs Revenue

ProPhase Labs had revenue of $2.47M in the quarter ending June 30, 2024, a decrease of -81.28%. This brings the company's revenue in the last twelve months to $17.97M, down -77.12% year-over-year. In the year 2023, ProPhase Labs had annual revenue of $44.38M, down -63.81%.

Revenue (ttm)
$17.97M
Revenue Growth
-77.12%
P/S Ratio
1.95
Revenue / Employee
$159,044
Employees
113
Market Cap
27.66M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202344.38M-78.26M-63.81%
Dec 31, 2022122.65M43.61M55.17%
Dec 31, 202179.04M64.53M444.59%
Dec 31, 202014.51M4.64M46.96%
Dec 31, 20199.88M-3.25M-24.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Outset Medical 114.73M
Neuronetics 72.07M
Burning Rock Biotech 70.15M
Curis 10.16M
Surrozen 10.00M
Daré Bioscience 2.84M
Beyond Air 1.78M
Lumos Pharma 1.49M
Revenue Rankings

PRPH News

More News